Publication: Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation
dc.contributor.author | Araque Arroyo, Patricia | |
dc.contributor.author | Ubago Perez, Ruth | |
dc.contributor.author | Fernandez Feijoo, Maria Amalia | |
dc.contributor.author | Calleja Hernandez, Miguel Angel | |
dc.contributor.authoraffiliation | [Araque Arroyo,P; Ubago Perez,R; Fernandez Feijoo,MA; Calleja Hernandez,MA] Department of Pharmacy, Virgen de las Nieves University Hospital, Granada, Spain. | es |
dc.date.accessioned | 2012-10-09T12:18:12Z | |
dc.date.available | 2012-10-09T12:18:12Z | |
dc.date.issued | 2011-02-24 | |
dc.description | Case Reports; Journal Article; | es |
dc.description.abstract | A 75-year-old man diagnosed with lower esophageal adenocarcinoma suffered from epirubicin extravasation during the second cycle of neoadjuvant chemotherapy with epirubicin and oxaliplatin. A full recovery was achieved after treatment with dexrazoxane (Cardioxane® ). This is the first time in our hospital that extravasation of an anthracycline has been treated with dexrazoxane. We used Cardioxane® , approved for the prevention of anthracycline-induced cardiotoxicity, while Savene® is indicated for the treatment of anthracycline extravasation. The treatment was effective, and the selection of Cardioxane® (seven-fold cheaper than Savene® ) yielded a cost saving. Consequently, Cardioxane® has been included in our guidelines for anthracycline extravasation. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Arroyo PA, Perez RU, Feijoo MA, Hernandez MA. Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation. J Can Res Ther 2010;6:573-4 | es |
dc.identifier.doi | 10.4103/0973-1482.77081 | |
dc.identifier.essn | 1998-4138 | |
dc.identifier.issn | 0973-1482 | |
dc.identifier.pmid | 21358106 | |
dc.identifier.uri | http://hdl.handle.net/10668/554 | |
dc.journal.title | Journal of Cancer Research and Therapeutics | |
dc.language.iso | en | |
dc.publisher | Medknow Publications | es |
dc.relation.publisherversion | http://www.cancerjournal.net/text.asp?2010/6/4/573/77081 | es |
dc.rights.accessRights | open access | |
dc.subject | Anciano | es |
dc.subject | Antineoplásicos | es |
dc.subject | Análisis Costo-Beneficio | es |
dc.subject | Epirrubicina | es |
dc.subject | Extravasación de Materiales Terapéuticos y Diagnósticos | es |
dc.subject | Humanos | es |
dc.subject | Masculino | es |
dc.subject | Razoxano | es |
dc.subject | Resultado del Tratamiento | es |
dc.subject | Anthracycline | es |
dc.subject | Chemotherapy | es |
dc.subject | cost | es |
dc.subject | Desraxozane | es |
dc.subject | extravasation | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Doxorubicin::Epirubicin | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Extravasation of Diagnostic and Therapeutic Materials | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Check Tags::Male | es |
dc.subject.mesh | Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Piperazines::Diketopiperazines::Razoxane | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome | es |
dc.subject.mesh | Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged | es |
dc.title | Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1